As healthcare heads into an increasingly digital future, NuroKor Bioelectronics is taking great pains to make pain a thing of the past. And their expansion into sports recovery and performance opens the door to a much wider market.
What is NuroKor Bioelectronics?
For those of you in pharmacy who are unfamiliar with NuroKor (I suspect an increasing minority), NuroKor is a bioelectrical technology company which works with the body’s bio-electricity. They focus on the software behind the hardware (a little bit like the pain behind the person).
Anyone can claim they’re treating someone by jolting electricity into a body, (with varying degrees of brutality) but it’s the patterns and frequency of the electricity which separates an electric shock from bioelectrical pain treatments.
Consistently basing their developments on evidence-based research, what sets NuroKor apart is their programmes with varying patterns and frequencies of electricity to achieve the best solution for each use.
NuroKor LifeTech has several uses, including:
- Pain Management
- Sports and Injury Recovery
- Training Performance
- Reducing Inflammation
- Preventing Muscular Atrophy
How does NuroKor work?
Let’s begin with the obvious. Because it works with the body’s bioelectricity, the NuroKor device sends electric impulses through the electrode patches the user attaches to the target area on their body.
Peripheral nerve stimulation (PNS) is one of the forms of stimulation that the device uses to manage pain, which for a pharmacy is likely to be the primary purpose for patients. These impulses travel via the skin and trigger responses from the peripheral nervous system and influence the desired effect.
The device itself has 5 programmes, for different types of treatment:
- Pain – for pain reduction
- Pain Plus – for pain reduction and anti-inflammation
- Recovery – for use after exercise
- Performance – for use during exercise
- Microcurrent – a setting with no sensation for body repair after injury or exercise
What do Nurokor’s users say?
NuroKor recently surveyed (2021) 112 of its users. The survey showed that people generally experienced reduction in severity of their pain after NuroKor use. Here are some of the key notes of the study:
- All participants (100%) reported a decrease in pain intensity following treatment with NuroKor mibody, and
80% responded ‘yes’ to having a reduction in frequency or duration of pain at the time of survey response.
- A majority (60%) of participants also decreased their use of pain relief medication following treatment
with the device.
- Participants gave an average NRS score of 8.1 (Standard Deviation: 1.9) when asked how beneficial they found the treatment
with NuroKor (NRS 10 = very satisfied).
What kind of pain does it treat?
NuroKor devices manage musculoskeletal pain, so some of the popular uses are for:
- Back Pain
- Neck Pain
- Frozen Shoulder
Does that mean NuroKor replaces pain medication?
For patients living with Chronic pain, medication is often problematic.
Obviously replacing painkillers altogether is the ambition, and in some cases this is achievable.
Of course people won’t come off their medication in every case. Even NuroKor are careful with their wording on their own website…the initial aim is to reduce dependency on pain medication. But whilst it might not replace medication completely, reducing reliance on opioids, painkillers and anti-inflammatories, as well as all the accompanying side-effects, is a massive stride for healthcare.
How can pharmacists work with NuroKor?
Stocking NuroKor products just as you’d stock any product is the most basic way of incorporating NuroKor into your pharmacy.
But offering continuous pain management consultations, having live demonstrations and group Q&A sessions on Living with Chronic Pain are far more engaging options that add value to your community.
Sounds like a lot of work – will it make me money?
Even if you’re purely revenue-focused, these are prime ways of generating some excitement in your pharmacy – offering events and Live Demos are footfall-drivers. (They also help sell the product, too)
Think about the Apple Store, and how they display their products. Treat your NuroKor devices like an iPhone. Showcase it.
And of course, if you aren’t purely revenue-focused, if you believe in the reduction of reliance on painkillers in your community as well? Then NuroKor and this way of promoting it are a match made in heaven.
What’s the future of NuroKor?
Whilst NuroKor isn’t currently mainstream, it’s emerging. Between pain management and sports and injury recovery & performance, it’s easy to envisage a future where every household has technology like this. Especially when you consider the fact they also have devices for horses and dogs…
It’s also exciting to think that NuroKor has had such positive feedback from their users, when the field of research is still relatively young compared to other medical fields.
As the research improves, so will the effectiveness of the devices. As the effectiveness of the devices improve, the reliance on painkillers decreases.
Continuous Advances could have wider ripple effects on healthcare
As advances are made, the prospective use of Bioelectronics throughout healthcare becomes more widespread. For instance, bioelectric neuromodulation’s anti-inflammatory effects are already being investigated for use with gastrointestinal purposes. This is just one example of a whole body (literally) of potential for the work around bioelectricity.
Because of NuroKor’s focus on software, it’s worth bearing in mind that developments in other areas of software. The development of Artificial Intelligence and Big Data impacts the effectiveness of NuroKor, and other similar technologies. As these other technologies develop, research becomes more reliable, clearer and catalyses the whole development process. Evolving the use and implementation of the devices with developments in technology like the metaverse is another area that NuroKor, and all digital healthcare have cause for excitement.
Reducing the Burden on the NHS
Bioelectronic devices such as those developed by NuroKor represent potentially major savings for the NHS. Not only through its preventative nature, but through the reduction in painkiller use and consultation time. (If people aren’t in pain, they don’t feel any need to contact the doctor).
Taken from an article published by NuroKor:
With this in mind, the demonstrated ability of bioelectric technology to treat non-healing ulcers, combined with existing population data has shown that, if applied at scale, NuroKor could (conservatively) save £50,000 per year per NHS clinical commissioning group (CCG) in wound care alone.
With 211 CCGs, a national roll-out could, theoretically, then lead to annual savings of over £10M to the NHS in this one-use case.